Form D · Other Health Care
Biomeme Inc
Philadelphia, PA · CIK 0001596481
Offering snapshot reported May 1, 2017 · SEC filing
- Reported sold
- $4.51M Offering amount: $5.17M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 17, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 1, 2017 | Initial | $4,505,577 | No comparison | 35 | SEC filing |
| Jan 29, 2014 | Initial | $992,799 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-285839
Source: Form D, filed May 1, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc De John | Director, Executive |
| Marc De Jong | Director, Executive |
| Max Perelman | Director, Executive |
| Jesse Van Westrienen | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1015 Chestnut St. Suite 1401
Philadelphia, PA, 19107
Philadelphia, PA, 19107